Although it is not known why hepatic de novo lipogenesis, an insulin-sensitive pathway, is activated in insulin resistance, the prevalence of NAFLD is up to three times higher in patients with type 2 diabetes compared to the general population (~90% versus 30%) [28]. Here, INS is linked to Insulin resistance.